SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

O60218 (AK1BA_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member B10 UniProtKBInterProSTRINGInteractive Modelling

316 aa; Sequence (Fasta)

Available Structures

20 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestatmonomer1-316
100NAP;TOL;
Crystal structure of human AKR1B10 complexed with NADP+ and sulindacmonomer1-316
99.37NAP;SUZ;
Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008monomer1-316
99.37NAP;UV8;EDO;
Human AKR1B10 mutant V301L complexed with NADP+ and fidarestatmonomer1-316
99.68NAP;FID;CL;
Crystal structure of human AKR1B10 complexed with NADP+ and JF0049monomer1-316
99.37NAP;F49;EDO;
Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzymemonomer1-316
99.37NAP;EDO;
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388monomer1-316
99.37NAP;388;EDO;
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319monomer1-316
99.37NAP;1WX;EDO;
Crystal structure of the methylated wild-type AKR1B10 holoenzymemonomer1-316
100NAP;EDO;
Crystal structure of human AKR1B10 complexed with NADP+ and JF0064monomer1-316
99.37NAP;64I;
Crystal structure of AKR1B10 complexed with NADP+monomer1-316
99.68NAP;
Human AKR1B10 mutant V301L complexed with NADP+ and sorbinilmonomer1-316
99.68NAP;SBI;
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184monomer1-316
99.37NAP;MK4;EDO;
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181monomer1-316
99.37NAP;W8X;EDO;
Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204monomer1-316
99.37NAP;DQP;EDO;
Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl estermonomer1-316
99.68QAP;NAP;
Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acidmonomer1-316
99.68FLF;NAP;
Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestatmonomer1-316
99.68NAP;ZST;NA;
Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestatmonomer1-316
99.68EPR;NAP;
Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diolmonomer4-316
100NAP;8QL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4ga8.1.Amonomer0.881-316
NAP;99.68